Paclitaxel Induced Acute ST Elevation Myocardial Infarction: A Rare Case Report
Published: October 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/21396.8614
Gautam Rawal, Sankalp Yadav, Raj Kumar
1. Attending Consultant, Respiratory Intensive Care, Max Super Specialty Hospital, Saket, New Delhi, India.
2. General Duty Medical Officer-II, Department of Medicine and TB, Chest Clinic Moti Nagar, North Delhi Municipal Corporation, New Delhi, India.
3. Senior Consultant and Incharge, Respiratory Intensive Care, Max Super Specialty Hospital, Saket, New Delhi, India.
Correspondence
Dr. Gautam Rawal,
Flat No. 417, Dhruva Apartments, Plot No. 4, I P Extension, Patparganj, Delhi -110092, India.
E-mail: drgautamrawal@hotmail.com
Paclitaxel, is a frequently used anti-neoplastic agent and is included in various chemotherapy regimens. The life threatening cardio toxicity associated with its use and the still unclear pathophysiology, has limited the use of this drug. Acute myocardial infarction is a rare adverse event associated with this drug. We report a case of acute ST-elevation myocardial infarction induced by paclitaxel infusion in a patient of oesophageal carcinoma who was saved by percutaneous primary intervention. The authors emphasize the awareness of this side effect of Paclitaxel among the clinicians.
[
FULL TEXT ] | [ PDF]